| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/26/1989 | WO1989000582A2 Human granulocyte-macrophage colony stimulating factor and muteins thereof |
| 01/26/1989 | WO1989000427A1 Pharmaceutical therapeutic use of a glutathione derivative |
| 01/26/1989 | WO1988007576A3 Vascular anticoagulant proteins, dnas which code for them, manufacture and application thereof |
| 01/25/1989 | EP0300988A2 Tissue factor inhibitor |
| 01/25/1989 | EP0300969A2 Polyethylene glycol carbaminates |
| 01/25/1989 | EP0300960A2 Pharmaceutical compositions and lactosyl compounds, and their preparation |
| 01/25/1989 | EP0300725A1 Tetrahydroisoquinolin-2-yl derivatives as thromboxane A2 antagonists |
| 01/25/1989 | EP0300676A2 Tetrahydrocarbazole 1-alkanoic acids |
| 01/25/1989 | EP0300675A2 Method for the improvement of cyclosporine therapy |
| 01/25/1989 | EP0300541A1 8,9-anellated-1,2,3,4-tetrahydro-beta-carboline derivatives |
| 01/25/1989 | EP0300099A1 New pentasaccharides |
| 01/25/1989 | EP0300030A1 Human proteins having anticoagulant and anti-inflammatory activity |
| 01/25/1989 | CN1030609A Protein with 8th activity factor,process for its preparation using genetic engineering cell and pharmaceutical composition containing it |
| 01/25/1989 | CN1030586A Cycloalkylamides of (8beta)-1-alkyl-6-(substituted) ergolines |
| 01/24/1989 | CA1249293A1 5,6-epoxy-7-oxabicycloheptane substituted amino prostaglandin analogs useful in the treatment of thrombotic disease |
| 01/24/1989 | CA1249292A1 5,6-epoxy-7-oxabicycloheptane substituted ethers useful in the treatment of thrombotic disease |
| 01/24/1989 | CA1249291A1 7-oxabicycloheptane substituted aryl amino prostaglandin analogs and their use in inhibiting platelet aggregation and bronchoconstriction |
| 01/24/1989 | CA1249290A1 7-oxabicycloheptane ethers |
| 01/24/1989 | CA1249289A1 7-oxabicycloheptane substituted thio prostaglandin analogs |
| 01/19/1989 | DE3722647A1 Galenische verwendung eines tripeptids als arzneimittel Pharmaceutical use of a tripeptide as drug |
| 01/18/1989 | EP0299782A2 Expression vectors for the production of human Granulocyte-Macrophage Colony Stimulation Factor in a mammalian cell host(18.05.92) |
| 01/18/1989 | EP0299761A1 Anti-inflammatory aryl derivatives |
| 01/18/1989 | EP0299706A2 Nonglycosylated plasminogen activator and method of preparation |
| 01/18/1989 | EP0299457A2 Novel benzothiophenes having antiallergic activity and both novel and other selected benzothiophenes having activity for treating acute respiratory distress syndrome |
| 01/18/1989 | EP0299397A2 Peptides with vasorelaxing, natriuretic and diuretic activities, preparation process, agents containing them and their use |
| 01/18/1989 | EP0299379A1 Pentadienamide PAF-antagonists |
| 01/18/1989 | EP0299376A2 Prostanoid compositions and methods for reducing blood vessel dysfunction |
| 01/18/1989 | EP0299209A2 Pyrazolopyridine compound and processes for preparation thereof |
| 01/18/1989 | EP0299053A1 Des-epidermal growth factor plasminogen activators |
| 01/18/1989 | CN1030425A Pasteurizable, freeze-driable hemoglobin-based blood substitute |
| 01/17/1989 | US4798897 Isoquinoline derivatives |
| 01/17/1989 | US4798843 Hypotensive agents |
| 01/17/1989 | US4798811 Combination preparation |
| 01/17/1989 | US4798796 Cell lines and their use for the production plasminogen activators |
| 01/17/1989 | CA1248947A1 Pyrrol-1-ylphenyldihydropyridazinones, their preparation and their use |
| 01/12/1989 | WO1989000200A1 Peptides and antibodies that inhibit platelet adhesion |
| 01/12/1989 | WO1989000197A1 Improved processes for the treatment of vascular disease |
| 01/12/1989 | WO1989000191A1 Novel thrombolytic proteins |
| 01/12/1989 | WO1989000049A1 Method and therapeutic compositions for the prevention of fibrin deposition or adhesions |
| 01/11/1989 | EP0298820A1 Peptide derivatives and their therapeutic application |
| 01/11/1989 | EP0298466A2 Substituted alkene carboxylic acid amides and derivatives |
| 01/10/1989 | US4797415 Diuretics for gout |
| 01/10/1989 | US4797399 Piperazine compounds and antithrombotic pharmaceutical composition comprising the same |
| 01/10/1989 | US4797390 Inositol triphosphate pharmaceutical compositions |
| 01/10/1989 | CA1248526A1 [3.2.0]bicycloheptanone oxime ethers with valuable therapeutic properties |
| 01/10/1989 | CA1248525A1 Carbacyclins, process for their manufacture and their use as medicaments |
| 01/10/1989 | CA1248472A1 Monoclonal antibodies specific to in vivo fragments derived from fibrinogen |
| 01/10/1989 | CA1248449A1 Process for purifying factor viii: c |
| 01/04/1989 | EP0297987A1 Process for the preparation of dextro (3-pyridyl)-3-1H,3H-pyrrolo [1,2-c] thiazole-7-carboxylic acid |
| 01/04/1989 | EP0297882A2 Hybrid plasminogen activators |
| 01/04/1989 | EP0297860A1 Method and therapeutic compositions for the prevention of fibrin deposition or adhesions |
| 01/04/1989 | EP0297855A1 Aminocyclopentyl ethers and their preparation and pharmaceutical formulation |
| 01/04/1989 | EP0297853A1 Preparation of 5-biphenylmethoxy-3-hydroxy-2- piperdinylcyclopentyl-4-heptenoic acid |
| 01/04/1989 | EP0297768A1 Arylthioalkylphenyl carboxylic acids, compositions containing same and method of use |
| 01/04/1989 | EP0297681A2 Iron-calcium mineral supplements with enhanced bioavailability |
| 01/04/1989 | EP0297294A1 Process for preparing a solution with a high specific volume activity of a protein with a tissue plasminogen activator activity (t-PA), solution containing the protein with t-PA activity and use of the solution in human and veterinary medicine |
| 01/03/1989 | US4795814 Process for preparing novel dihydropyridine derivatives |
| 01/03/1989 | CA1248116A1 Biologically active substance called girolin, extracted from a sponge (pseudodaxinyssa cantharella), preparation process and pharmaceutical compositions containing same |
| 01/03/1989 | CA1248110A1 Piperazine derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient |
| 12/29/1988 | WO1988010310A1 Bovine granulocyte-macrophage colony stimulating factor |
| 12/29/1988 | WO1988010295A1 MODIFIED FACTOR VII/VIIa |
| 12/29/1988 | WO1988010266A1 Cysteine proteinase inhibitor |
| 12/29/1988 | WO1988010117A1 Composition based on heparin micropolysaccharides, active when administered orally |
| 12/29/1988 | WO1988010113A1 Compound, composition and method for the reduction of lipids the modification of the affinity of hemoglobin for oxygen and the prevention of platelet aggregation |
| 12/28/1988 | EP0297066A1 Novel fibrinolytic enzymes |
| 12/28/1988 | EP0296892A2 Novel linear derivatives of arginine vasopressin antagonists |
| 12/28/1988 | EP0296748A1 Cycloalkylamides of (8Beta)-1-alkyl-6-(substituted) ergolines |
| 12/28/1988 | EP0296661A2 Single-phase composition containing a perfluorinated oil and one or more surfactant(s), useful as an excipient for cosmetic and dermatologic formulations, as well as for biomedical applications |
| 12/28/1988 | EP0296455A1 Thiazolopyridine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same |
| 12/28/1988 | EP0296413A2 Hybrid protein C and method for its preparation |
| 12/28/1988 | CN88103114A Heterocyclic compounds |
| 12/28/1988 | CN88103112A Amides |
| 12/28/1988 | CN88102356A 1,3-dioxanes |
| 12/27/1988 | US4794197 Hemochromatosis; blood disorders |
| 12/27/1988 | US4794014 Counteracting deliterious effects of heavy metals, radiation and smoking |
| 12/21/1988 | EP0295940A2 Method of suppressing the thermal degradation of urokinase |
| 12/21/1988 | EP0295679A2 Physiologically-active novel peptides |
| 12/21/1988 | EP0295597A2 Factor VIII:C-like molecule with a coagulant activity |
| 12/21/1988 | EP0295476A2 Inclusion complexes of dipyridamole with cyclodextrins |
| 12/21/1988 | EP0295331A2 Use of vitamin E for the preparation of medicaments for use in normalizing the blood coagulation in the therapy with omega-3-type highly unsaturated fatty acids |
| 12/21/1988 | CN88103015A Cyclic anticoagulant peptides |
| 12/21/1988 | CN88103009A Cyclic anticoagulant peptides |
| 12/20/1988 | CA1247091A1 Low molecular weight xylane sulfates, and their preparation |
| 12/20/1988 | CA1247085A1 Process for preparing n-carboxyalkylproline- containing tripeptides |
| 12/15/1988 | WO1988009817A1 Cloning and expression of human tissue factor |
| 12/15/1988 | WO1988009813A1 Novel proteins with factor viii activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them |
| 12/15/1988 | WO1988009811A1 Proteins and derivatives thereof |
| 12/15/1988 | WO1988009792A1 Ester-substituted thienotriazolodiazepine compounds and their medicinal use |
| 12/14/1988 | EP0295161A1 3-Acylaminomethyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine derivatives, their preparation and therapeutical use |
| 12/14/1988 | EP0294973A1 Dopamine-beta-hydroxylase inhibitors |
| 12/14/1988 | EP0294647A2 Thiadiazinones |
| 12/14/1988 | CN88102569A Beta-d-phenyl-thioxyloside, method for preparing them and use as theapeutics |
| 12/14/1988 | CN88100685A Huamn interleukin-3 and muteins thereof |
| 12/13/1988 | US4791203 Cardiotonic agents |
| 12/13/1988 | US4791202 5-(6-imidazo(1,2-a)-pyridyl)pyridine derivatives |
| 12/13/1988 | US4791195 Anticoagulants, antithrombin |
| 12/13/1988 | US4791136 Pharmacologically active ketones and use |
| 12/13/1988 | US4791108 Antidepressants |
| 12/13/1988 | US4791100 Novel polypeptides with a blood coagulation-inhibiting action, processes for their preparation and isolation, their use and agents containing them |
| 12/13/1988 | CA1246594A1 Prostaglandins |